Gene A, upregulated by mutant KRAS, is a potential therapeutic target for lung cancer

被引：0
|
作者：
Kawabe, Nozomi [1 ]
Muraki, Nao [1 ]
Tanaka, Ichidai [2 ]
Sunaga, Noriaki [3 ]
Sato, Mitsuo [1 ]
机构：
[1] Nagoya Univ, Dept Integrated Hlth Sci, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan
[3] Gunma Univ, Grad Sch Med, Dept Resp Med, Maebashi, Gumma, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3031
引用
收藏
页码：1547 / 1547
页数：1
相关论文
共 50 条
  • [31] Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
    Lin, Mengmeng
    Li, Yingying
    Wang, Shiyuan
    Cao, Bo
    Li, Chunyu
    Li, Guohui
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [32] Identification of thymidylate synthase as a potential therapeutic target for lung cancer
    K Takezawa
    I Okamoto
    S Tsukioka
    J Uchida
    M Kiniwa
    M Fukuoka
    K Nakagawa
    British Journal of Cancer, 2010, 103 : 354 - 361
  • [33] Identification of thymidylate synthase as a potential therapeutic target for lung cancer
    Takezawa, K.
    Okamoto, I.
    Tsukioka, S.
    Uchida, J.
    Kiniwa, M.
    Fukuoka, M.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 354 - 361
  • [34] CARD9 as a potential therapeutic target in lung cancer
    Sheng, Ruanmei
    Yang, Zhiwen
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (12): : 1621 - 1626
  • [35] miR-137: a potential therapeutic target for lung cancer
    Liu, Shuanshuan
    Ruan, Yanyun
    Chen, Xu
    He, Bao
    Chen, Qi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [36] Current therapy of KRAS-mutant lung cancer
    Ghimessy, Aron
    Radeczky, Peter
    Laszlo, Viktoria
    Hegedus, Balazs
    Renyi-Vamos, Ferenc
    Fillinger, Janos
    Klepetko, Walter
    Lang, Christian
    Dome, Balazs
    Megyesfalvi, Zsolt
    CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1159 - 1177
  • [37] Closing the door on KRAS-mutant lung cancer
    Cully, Megan
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 747 - 747
  • [38] Targeting immunosuppressive mechanisms in KRAS mutant lung cancer
    Havel, Lauren Smith
    Gao, Dingcheng
    Daniel, Jennifer S.
    Altorki, Nasser K.
    Mittal, Vivek
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S23 - S24
  • [39] Current therapy of KRAS-mutant lung cancer
    Aron Ghimessy
    Peter Radeczky
    Viktoria Laszlo
    Balazs Hegedus
    Ferenc Renyi-Vamos
    Janos Fillinger
    Walter Klepetko
    Christian Lang
    Balazs Dome
    Zsolt Megyesfalvi
    Cancer and Metastasis Reviews, 2020, 39 : 1159 - 1177
  • [40] Closing the door on KRAS-mutant lung cancer
    Megan Cully
    Nature Reviews Drug Discovery, 2016, 15 : 747 - 747
12345